Chemotherapy-associated polyneuropathy: problems and objects at the current stage of neurological assistance to oncological patients
- Authors: Abbasov F.A1, Anikina M.A1, Zimnyakova O.S1, Davtyan A.A1, Bril E.V1
-
Affiliations:
- FSBI “State Scientific Center of the Russian Federation “Federal Medical Biophysical Center n.a. A.I. Burnazyan FMBA of Russia"
- Issue: No 17 (2017)
- Pages: 78-82
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/290007
- ID: 290007
Cite item
Abstract
Keywords
Full Text
About the authors
F. A Abbasov
FSBI “State Scientific Center of the Russian Federation “Federal Medical Biophysical Center n.a. A.I. Burnazyan FMBA of Russia"
M. A Anikina
FSBI “State Scientific Center of the Russian Federation “Federal Medical Biophysical Center n.a. A.I. Burnazyan FMBA of Russia"
O. S Zimnyakova
FSBI “State Scientific Center of the Russian Federation “Federal Medical Biophysical Center n.a. A.I. Burnazyan FMBA of Russia"
A. A Davtyan
FSBI “State Scientific Center of the Russian Federation “Federal Medical Biophysical Center n.a. A.I. Burnazyan FMBA of Russia"
E. V Bril
FSBI “State Scientific Center of the Russian Federation “Federal Medical Biophysical Center n.a. A.I. Burnazyan FMBA of Russia"
Email: e.brill@inbox.ru
PhD, Associate Professor at the Department of Neurology FSBEI FPE RMACPE of RMH, Chief Neurologist of FMBA of Russia, Head of Federal Neurological Center
References
- Ferlay J., Soerjomataram I., Ervik M., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin D.M., Forman D., Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer. 2015;136(5):E359-86.
- Cavaletti G., Marmiroli P. Chemotherapy-induced neurotoxicity Nat. Rev. Neurol. 2010;6(12):657-66.
- Grisold W., Cavaletti G., Windebank A.J. Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and preventbn. Neuro. Oncol. 2012;14(Suppl 4):iv45-54.
- Brzezinski К. Chemotherapy-induced polyneuropathy. Part I. Pathophysiology. Contemp. Oncol. (Pozn). 2012;16(1):72-8.
- Moghadamyeghaneh Z., Alizadeh R.F., Phelan M., Carmichael J.C., Mills S., Pigazzi A., Zell J.A., Stamos M.J. Trends in colorectal cancer admissions and stage at presentation: impact of screening. Surg. Endosc. 2016;30(8): 3604-10.
- Staff N.P., Grisold A., Grisold W., Windebank A.J. Chemotherapy-Induced Peripheral Neuropathy: A Current Review. Ann. Neurol. 2017;81(6):772-81.
- Briani C., Vitaliani R., Grisold W., Honnorat J., Graus F., Antoine J.C., Bertolini G., Giometto B.; PNS Euronetwork. Spectrum of paraneoplastic disease associated with lymphoma. Neurology. 2011;76(8):705-10.
- Mendoza T.R., Wang X.S., Williams L.A., Shi Q., Vichaya E.G., Dougherty P.M., Thomas S.K., Yucel E., Bastida C.C., Woodruff J.F., Cleeland C.S. Measuring therapy-induced peripheral neuropathy: preliminary development and validation of the Treatment-induced Neuropathy Assessment Scale. J. Pain. 2015;16(10): 1032-43.
- Brzezinski К. Chemotherapy-induced peripheral neuropathy. Part II. Prevention. Contemp. Oncol. (Pozn). 2012;16(3):258-61.
- Cavaletti G., Zanna C. Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity. Eur. J. Cancer. 2002;38(14):1832-37.
- Холодова Н.Б., Сотников В.М., Добровольская Н.Ю., Особенности проявления и лечение постхимиотерапевтической полинейропатии. Вестник Российского научного центра рентгенорадиологии. 2010;10.
- Королева Е.С., Алифирова В.М., Гольдберг В.Е. и др. Клиническое, нейрофизиологическое и иммунологическое обследование пациентов с поражением периферических нервов, Бюллетень сибирской медицины. 2013;12(5):39-45.
- Королева Е.С., Алифирова В.М., Гольдберг В.Е. и др. Поражение периферических нервов паранеопластического и токсического генеза у пациентов, страдающих раком молочной железы и мелкоклеточным раком легкого. Неврологический журнал. 2013; 18(6):27-32.
- McKeage M.J. Comparative adverse effect profiles of platinum drugs. Drug Saf. 1995;13(4): 228-44.
- Grothey A. Clinical management of oxaliplatin-associated neurotoxicity. Clin. Colorectal Cancer. 2005;5(Suppl 1):S38-46.
- Postma T.J., Heimans J.J. Grading of chemotharapy-induced peripheral neuropathy. Ann. Oncol. 2000;11(5):509-13.
- Bakogeorgos M., Georgoulias V Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy. Expert Rev. Anticancer Ther. 2017;17(11):1045-60.
- Filipczak-Bryniarska I., Krzyzewski R.M., Kucharz J., Michalowska-Kaczmarczyk A., Kleja J., Woron J., Strzepek K., Kazior L., Wordliczek J., Grodzicki T., Krzemieniecki K. High-dose 8% capsaicin patch in treatment of chemotherapyinduced peripheral neuropathy: single-center experience. Med. Oncol. 2017;34(9):162.
- Carter G.T. Rehabilitation Management of Peripheral Neuropathy. Semin Neurol. 2005;25(2):229-37.